浙江医学教育
浙江醫學教育
절강의학교육
Zhejiang Medical Education
2015年
2期
52-53,42
,共3页
喘息样支气管炎%电动%雾化吸入%普米克令舒
喘息樣支氣管炎%電動%霧化吸入%普米剋令舒
천식양지기관염%전동%무화흡입%보미극령서
asthmatic bronchitis%electric%atomization%pulmicort respules
目的:探讨电动雾化吸入普米克令舒在预防喘息样支气管炎反复发作中的作用。方法:将68例反复发作≥2次的喘息样支气管炎患儿分成2组,对照组患儿出院后予常规口服止咳、抗过敏药物巩固治疗3~5天,观察组患儿出院后在常规巩固治疗基础上,加电驱动雾化吸入普米克令舒。对于IgE升高或有过敏史、遗传史者,2组均加孟鲁斯特口服(4mg qN )。随访1年,比较2组患儿喘息反复发作次数。结果:观察组复发率明显低于对照组,差异具有统计学意义( P<0.01)。结论:电动雾化吸入普米克令舒可有效预防喘息样支气管炎反复发作,值得临床推荐使用。
目的:探討電動霧化吸入普米剋令舒在預防喘息樣支氣管炎反複髮作中的作用。方法:將68例反複髮作≥2次的喘息樣支氣管炎患兒分成2組,對照組患兒齣院後予常規口服止咳、抗過敏藥物鞏固治療3~5天,觀察組患兒齣院後在常規鞏固治療基礎上,加電驅動霧化吸入普米剋令舒。對于IgE升高或有過敏史、遺傳史者,2組均加孟魯斯特口服(4mg qN )。隨訪1年,比較2組患兒喘息反複髮作次數。結果:觀察組複髮率明顯低于對照組,差異具有統計學意義( P<0.01)。結論:電動霧化吸入普米剋令舒可有效預防喘息樣支氣管炎反複髮作,值得臨床推薦使用。
목적:탐토전동무화흡입보미극령서재예방천식양지기관염반복발작중적작용。방법:장68례반복발작≥2차적천식양지기관염환인분성2조,대조조환인출원후여상규구복지해、항과민약물공고치료3~5천,관찰조환인출원후재상규공고치료기출상,가전구동무화흡입보미극령서。대우IgE승고혹유과민사、유전사자,2조균가맹로사특구복(4mg qN )。수방1년,비교2조환인천식반복발작차수。결과:관찰조복발솔명현저우대조조,차이구유통계학의의( P<0.01)。결론:전동무화흡입보미극령서가유효예방천식양지기관염반복발작,치득림상추천사용。
Objective ] To study the effects of electric-atomization inhalation of pulmicort respules in preventing repeated at-tacks of asthmatic bronchitis .[Method] A total of 62 chileren with asthmatic bronchitis who suffered from repeated attack ≥2 times were randomly divided into two groups .Control group was received conventional treatment of anti-cough and anti-al-lergy for 3-5days after discharge .On that basis ,electric-atomization inhalation of pulmicort respules were used in observa-tion group .Additional mantelukast (4mg ,po ,qn) were used in patients with elevated serum IgE ,allergy history or inherited his-tory in both groups .All patients were followed-up for one year and the recurrence rate of the wheezing were comparatively an-alyzed .[Result] The recurrence rate of the observation group was lower than that of the control group and the comparative dif-ference of the two groups was statically significant .[Conclusion] Electric-atomization inhalation of pulmicort respules could effectively prevent repeated attacks of asthmatic bronchitis .It holds promise for clinical application .